Clinical Trial Update: A Study of Docetaxel for Injection (Albumin Bound) in Patients With Advanced Pancreatic Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating an albumin-bound formulation of docetaxel in patients with advanced pancreatic cancer; the study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Docetaxel for Injection (Albumin Bound) (docetaxel (albumin-bound formulation))

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Advanced Pancreatic Cancer | Phase 3 | Status: NOT_YET_RECRUITING